PRESS RELEASE published on 04/01/2024 at 22:05, 2 years 4 months ago Zomedica Reports Record Revenue of $7.3 Million for the Fourth Quarter and $25.2 Million for the Full Year 2023, Reflecting 33% Annual Growth; 69% Gross Margin and $100.5 Million in Liquidity Zomedica Corp. reports consolidated financial results for Q4 and full year 2023, showing significant revenue growth and progress. CEO Larry Heaton highlights momentum and strategic acquisitions for future growth Financial Results Revenue Growth Acquisitions 2023 Zomedica Corp.
BRIEF published on 03/20/2024 at 11:35, 2 years 4 months ago Zomedica Announces Q4 and Full Year 2023 Financial Results Conference Financial Results Conference Call 2023 Performance Zomedica Veterinary Health
BRIEF published on 03/20/2024 at 11:35, 2 years 4 months ago Zomedica annonce la conférence sur les résultats financiers du quatrième trimestre et de l'exercice 2023 Résultats Financiers Zomedica Conférence Téléphonique Santé Vétérinaire Performances 2023
PRESS RELEASE published on 03/20/2024 at 11:30, 2 years 4 months ago Zomedica to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Monday, April 1, 2024, at 4:30 p.m. ET Zomedica Corp. (NYSE American: ZOM) to host conference call on April 1, 2024, discussing operational and financial highlights for Q4 and full year 2023. Company specializes in veterinary health products for companion animals Financial Results Conference Call Companion Animals Zomedica Corp. Veterinary Health
BRIEF published on 03/14/2024 at 11:35, 2 years 4 months ago Zomedica's TRUFORMA Demonstrates Superior Accuracy in Feline Hyperthyroidism Diagnosis Over CLIA Platforms Zomedica TRUFORMA Hyperthyroidism Veterinary Research Diagnostic Technology
BRIEF published on 03/14/2024 at 11:35, 2 years 4 months ago TRUFORMA de Zomedica démontre une précision supérieure dans le diagnostic de l'hyperthyroïdie féline par rapport aux plateformes CLIA Zomedica TRUFORMA Hyperthyroïdie Recherche Vétérinaire Technologie Diagnostique
PRESS RELEASE published on 03/14/2024 at 11:30, 2 years 4 months ago Zomedica Announces Publication of Research Concluding TRUFORMA(R) Platform is More Accurate Diagnostic Test for Feline Hyperthyroidism than Chemiluminescent Immunoassay (CLIA) Platform Zomedica Corp. announced the publication of a peer-reviewed research study comparing its TRUFORMA BAW diagnostic platform to CLIA platforms for feline hyperthyroidism diagnosis, showing superior accuracy and potential for early detection Zomedica Corp. TRUFORMA BAW Diagnostic Platform Feline Hyperthyroidism Peer-reviewed Research Study
BRIEF published on 03/13/2024 at 21:50, 2 years 4 months ago Zomedica Provides NYSE American Listing Update Reverse Stock Split Compliance Zomedica Share Price NYSE American
BRIEF published on 03/13/2024 at 21:50, 2 years 4 months ago Zomedica fournit une mise à jour de la cotation américaine au NYSE Zomedica Conformité Cours De L'action NYSE Américain Regroupement D'actions
PRESS RELEASE published on 03/13/2024 at 21:45, 2 years 4 months ago Zomedica Provides NYSE American Listing Update Zomedica Corp. announces ongoing dialogue with NYSE American regarding compliance with listing standards. Shares to remain listed as Company explores options Compliance Zomedica Corp. Share Price NYSE American Listing Standards
Published on 08/11/2026 at 14:30, 5 hours 56 minutes ago ACCESS Newswire Reports Second Quarter 2026 Results
Published on 08/11/2026 at 14:30, 5 hours 56 minutes ago AIAI Holdings' Constellation Network Launches Dôr Retail Intelligence: Transformational AI-Powered Retail Intelligence
Published on 08/11/2026 at 14:00, 6 hours 26 minutes ago First Canadian Graphite Signs Agreement with Groupe Nipi, in Collaboration with BBA, for its Preliminary Environmental Study at Lac Guéret Sud
Published on 08/11/2026 at 14:00, 6 hours 26 minutes ago First Canadian Graphite conclut une entente avec le Groupe Nipi en collaboration avec la firme BBA pour une étude environnementale préliminaire au Lac Guéret Sud
Published on 08/11/2026 at 13:30, 6 hours 56 minutes ago Nextech3D.ai CEO Evan Gappelberg Purchases 250,000 Shares in Open Market
Published on 08/11/2026 at 18:59, 1 hour 26 minutes ago EQS-Adhoc: thyssenkrupp nucera AG & Co. KGaA: SOEC realignment leads to adjustment of FY 2025/26 EBIT guidance; Order intake and sales outlook updated based on current business performance
Published on 08/11/2026 at 18:02, 2 hours 23 minutes ago TerraMaster lance officiellement son programme de mise à niveau du stockage : boostez votre capacité de stockage pour entrer dans l’ère de l’IA
Published on 08/11/2026 at 17:50, 2 hours 35 minutes ago Bilfinger Extends Contract of Group CEO Thomas Schulz by Another Five Years
Published on 08/11/2026 at 17:45, 2 hours 41 minutes ago Mobimo place un Green Bond de CHF 100 millions
Published on 08/11/2026 at 17:45, 2 hours 41 minutes ago Mobimo places Green Bond for CHF 100 million
Published on 08/11/2026 at 17:45, 2 hours 41 minutes ago DAMARTEX / Droits de vote bruts et réels au 31 juillet 2026
Published on 08/11/2026 at 17:40, 2 hours 46 minutes ago Infotel : Déclaration des transactions sur actions propres réalisées du 3 au 7 août 2026 dans le cadre du programme de rachat d’actions
Published on 08/10/2026 at 18:00, 1 day 2 hours ago AXA: Information relating to the number of voting rights and shares making up the share capital on 31/07/2026
Published on 08/10/2026 at 18:00, 1 day 2 hours ago AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/07/2026